CCO Oncology Podcast

Expert Insights on Optimal Current Management of Patients With Cholangiocarcinoma

Episode Summary

In an engaging discussion, Christine Chio, PharmD, BCOP; Lipika Goyal, MD; and Caroline Kuhlman, NP, share how they currently treat patients with cholangiocarcinoma, including initial diagnosis, biomarker testing to guide treatment, adverse event management, and patient counseling.

Episode Notes

In this episode, Lipika Goyal, MD, leads an engaging discussion with Christine Chio, PharmD, BCOP, and Caroline Kuhlman, NP, on current treatment of patients with cholangiocarcinoma. Topics include:

• Initial diagnosis
• Biomarker testing to guide treatment with immunotherapies and targeted agents
• Adverse event management
• Strategies for counseling patients

Presenters:

Christine Chio, PharmD, BCOP
Clinical Ambulatory GI Oncology Pharmacist
Department of Pharmacy
Massachusetts General Hospital
Boston, Massachusetts

Lipika Goyal, MD
Assistant Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Harvard Medical School
Attending Physician
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Caroline Kuhlman, NP
Department of Gastrointestinal Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Link to the full program on the CCO website: 
https://bit.ly/3JGDBCk